Elevance Health ELV Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 89.2%-0.2pp | 89.4%+0.5pp | 88.9%+0.2pp | 88.7%+0.1pp | 88.6%-0.2pp | |
| Net margin | 2.6%-0.2pp | 2.8%0.0pp | 2.8%0.0pp | 2.8%-0.4pp | 3.2%-0.2pp | |
| Returns | ||||||
| Return on equity | 12.1%-1.2pp | 13.3%+0.7pp | 12.6%+0.1pp | 12.5%-1.8pp | 14.2%-0.6pp | |
| Efficiency | ||||||
| Asset turnover | 1.6×0.0× | 1.7×0.0× | 1.6×0.0× | 1.6×0.0× | 1.6×0.0× | |
| Liquidity | ||||||
| Current ratio | 1.5×-0.1× | 1.5×0.0× | 1.6×+0.1× | 1.4×0.0× | 1.4×0.0× | |
| Leverage | ||||||
| Debt-to-equity | 0.7×0.0× | 0.7×0.0× | 0.7×+0.1× | 0.7×0.0× | 0.7×-0.1× | |
| Valuation | ||||||
| Market capitalization | $64.31B-17.5% | $77.91B+7.1% | $72.76B-14.4% | $85.05B-13.6% | $98.47B+15.1% | |
| Price / earnings | 12.3×-1.5× | 13.8×+0.6× | 13.2×-2.7× | 15.9×-0.8× | 16.6×+2.3× | |
| Price / sales | 0.3×-0.1× | 0.4×0.0× | 0.4×-0.1× | 0.4×-0.1× | 0.5×+0.1× | |
| Price / book | 1.5×-0.3× | 1.8×+0.1× | 1.7×-0.3× | 1.9×-0.4× | 2.3×+0.2× | |
| Dividend yield | 2.4%+0.4pp | 2%-0.1pp | 2.1%+0.3pp | 1.8%+0.3pp | 1.5%-0.2pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Elevance Health's ratios come from?
- Every ratio is computed from Elevance Health's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
